Regulatory Briefs: Guidance On Distributing Publications On Unapproved Uses; Export Certification Updates
This article was originally published in The Gray Sheet
FDA issues a revised draft guidance on distributing scientific publications on unapproved new uses of medical products. The agency enhances its export certification and tracking system. More regulatory news.
You may also be interested in...
One of FDA’s New Year’s resolutions seems to be emphasizing pediatric device development, as seen in a recent final rule on capturing data on pediatric use of devices, as well as a forthcoming draft guidance on pediatric uses of medical devices.
Physician Payment Sunshine Act finally goes to OMB. FDA signs regulatory agreements with Brazil, Australia and Canada. More regulatory news.
Rep. Henry Waxman is calling for the Obama administration to re-examine a final FDA guidance that gives companies a way to distribute journal articles discussing off-label uses for approved medical devices and drugs